These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 7911396

  • 21. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME.
    Cancer Res; 2000 Jun 01; 60(11):3081-7. PubMed ID: 10850460
    [Abstract] [Full Text] [Related]

  • 22. Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin.
    Zhang L, Hung MC.
    Oncogene; 1996 Feb 01; 12(3):571-6. PubMed ID: 8637714
    [Abstract] [Full Text] [Related]

  • 23. Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis.
    Kozaki K, Koshikawa K, Tatematsu Y, Miyaishi O, Saito H, Hida T, Osada H, Takahashi T.
    Oncogene; 2001 Jul 12; 20(31):4228-34. PubMed ID: 11464289
    [Abstract] [Full Text] [Related]

  • 24. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
    Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ, Welsch CW.
    Cancer Res; 1993 May 15; 53(10 Suppl):2272-8. PubMed ID: 8097963
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of intratracheal lung cancer development by systemic delivery of E1A.
    Chang JY, Xia W, Shao R, Hung MC.
    Oncogene; 1996 Oct 03; 13(7):1405-12. PubMed ID: 8875978
    [Abstract] [Full Text] [Related]

  • 26. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms.
    Yu D, Liu B, Tan M, Li J, Wang SS, Hung MC.
    Oncogene; 1996 Sep 19; 13(6):1359-65. PubMed ID: 8808711
    [Abstract] [Full Text] [Related]

  • 27. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.
    Zhang L, Lau YK, Xia W, Hortobagyi GN, Hung MC.
    Clin Cancer Res; 1999 Feb 19; 5(2):343-53. PubMed ID: 10037184
    [Abstract] [Full Text] [Related]

  • 28. p185neu expression in human lung adenocarcinomas predicts shortened survival.
    Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L, Robinson RA.
    Cancer Res; 1990 Aug 15; 50(16):5184-7. PubMed ID: 1974168
    [Abstract] [Full Text] [Related]

  • 29. Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene.
    Gum R, Wang SW, Lengyel E, Yu D, Hung MC, Juarez J, Boyd D.
    Anticancer Res; 1995 Aug 15; 15(4):1167-72. PubMed ID: 7653995
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
    Ren XL, Xu YM, Bao W, Fu HJ, Wu CG, Zhao Y, Li ZK, Zhang J, Li SQ, Chen WQ, Wang T, Zhang R, Zhang LH, Qian GS, Chen SY, Jia LT, Yang AG.
    Cancer Lett; 2009 Aug 28; 281(2):134-43. PubMed ID: 19339104
    [Abstract] [Full Text] [Related]

  • 31. Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.
    Giatromanolaki A, Koukourakis MI, O'Byrne K, Kaklamanis L, Dicoglou C, Trichia E, Whitehouse R, Harris AL, Gatter KC.
    Anticancer Res; 1996 Aug 28; 16(6B):3819-25. PubMed ID: 9042264
    [Abstract] [Full Text] [Related]

  • 32. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.
    Onn A, Isobe T, Itasaka S, Wu W, O'Reilly MS, Ki Hong W, Fidler IJ, Herbst RS.
    Clin Cancer Res; 2003 Nov 15; 9(15):5532-9. PubMed ID: 14654533
    [Abstract] [Full Text] [Related]

  • 33. In vivo overexpression of c-erbB-2 oncoprotein in xenografts of mice implanted with human colon cancer lines.
    Yang JL, Hanley JR, Yu Y, Berney CR, Russell PJ, Crowe PJ.
    Anticancer Res; 1997 Nov 15; 17(5A):3463-8. PubMed ID: 9413188
    [Abstract] [Full Text] [Related]

  • 34. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
    Yi ES, Harclerode D, Gondo M, Stephenson M, Brown RW, Younes M, Cagle PT.
    Mod Pathol; 1997 Feb 15; 10(2):142-8. PubMed ID: 9127320
    [Abstract] [Full Text] [Related]

  • 35. Tumorigenicity, invasion and metastasis of the small cell lung cancer cell line NCI-H69 and two derivative lines MOG-H69V and MOG-H69VZ.
    Khan MZ, McNicol AM, Freshney RI.
    Anticancer Res; 1996 Feb 15; 16(4A):1659-69. PubMed ID: 8712684
    [Abstract] [Full Text] [Related]

  • 36. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
    Wang ZX, Lu BB, Yang JS, Wang KM, De W.
    J Surg Res; 2011 Nov 15; 171(1):127-35. PubMed ID: 20338593
    [Abstract] [Full Text] [Related]

  • 37. Macrophage colony-stimulating factor gene transduction into human lung cancer cells differentially regulates metastasis formations in various organ microenvironments of natural killer cell-depleted SCID mice.
    Yano S, Nishioka Y, Nokihara H, Sone S.
    Cancer Res; 1997 Feb 15; 57(4):784-90. PubMed ID: 9044861
    [Abstract] [Full Text] [Related]

  • 38. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q.
    J Cancer Res Clin Oncol; 2003 Jan 15; 129(1):43-51. PubMed ID: 12618900
    [Abstract] [Full Text] [Related]

  • 39. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 15; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 40. Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice.
    Ogino H, Yano S, Kakiuchi S, Muguruma H, Ikuta K, Hanibuchi M, Uehara H, Tsuchida K, Sugino H, Sone S.
    Clin Cancer Res; 2008 Feb 01; 14(3):660-7. PubMed ID: 18245525
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.